Technoderma Medicines Completes Positive Ph2a Proof- of Concept Trial with Topical TDM-180935 Ointment for Atopic Dermatitis
CHENGDU,China,Jan. 6,2025-- Technoderma Medicines,Inc. ("the Company"),a clinical stage biopharmaceutical company,is pleased to report the Company has completed its Phase 2a clinical trial (